Show simple item record

dc.contributor.authorMogi, Chie
dc.contributor.authorFukuyama, Takaaki
dc.date.accessioned2019-05-13T12:03:19Z
dc.date.available2019-05-13T12:03:19Z
dc.date.issued2019
dc.identifier.issn2445-2874
dc.identifier.urihttp://hdl.handle.net/10396/18547
dc.description.abstractEpilepsy is the most common chronic neurological disorder in dogs and the almost lifelong administration of anti-epileptic drugs (AEDs) is recognized as the most successful treatment in veterinary medicine. Current pharmacological therapies for epilepsy have shown undesirable side effects. The dietary use of cannabidiol (CBD) in humans has shown therapeutic potential for the treatment of epileptic seizures. We administered CBD for 8 weeks to three dogs with epileptic seizures; decrease in the seizure interval was observed in two dogs, while one dog showed no improvement. Regarding the owners’ impressions, one reported considerable symptom improvement, one that the symptoms improved, and one that the symptoms remained unchanged.es_ES
dc.format.mimetypeapplication/pdfes_ES
dc.language.isoenges_ES
dc.publisherUniversidad de Córdoba, Departamento de Medicina y Cirugía Animales_ES
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/4.0/es_ES
dc.sourcePet Behaviour Science 7, 11-16 (2019)es_ES
dc.subjectCannabidioles_ES
dc.subjectDoges_ES
dc.subjectEpilepsyes_ES
dc.titleCannabidiol as a potential anti-epileptic dietary supplement in dogs with suspected epilepsy: three case reportses_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publisherversionhttp://www.uco.es/ucopress/ojs/index.php/pet/indexes_ES
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses_ES


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record